Cancer Care Delivery Research Steering Committee
The Cancer Care Delivery Research Steering Committee (CCDRSC) was established in February 2015. It serves to review and prioritize cancer care delivery research concepts to be conducted through the NCI Community Oncology Research Program (NCORP) Research Base mechanism.
The core committee membership includes representatives from the NCORP Research Bases, R01 investigators, community oncologists, biostatisticians, patient advocates, and NCI Staff. The CCDRSC meets monthly by conference call to review study concepts and approximately yearly in person to review the study portfolio. View the CCDRSC member roster as of May 30, 2024.
Studies under the purview of the CCDRSC will include:
- Descriptive observational studies to document the prevalence and variability of specific cancer care delivery models, approaches and/or processes
- Analytic observational studies to understand how the multi-level characteristics of care delivery models, approaches and processes influence quality, outcomes and access
- Intervention studies, including RCT designs, to test new models, approaches and/or processes of care delivery to improve quality, outcomes and access
A concept for a clinical trial contains scientific background, preliminary data, a hypothesis, and a plan for study implementation including statistical design. In December 2013, the SxQoLSC held a webinar on the required elements and statistical considerations for successful symptom management concepts.
Clinical Trials Planning Meetings (CTPMs)
CTPMs are held periodically and focus on specific clinical trial related topics. The following are important CCDRSC CTPMs:
- Health-Related Social Needs
In November 2022, the CCDRSC convened a CTPM that focuses on addressing health-related social needs to improve cancer care delivery and outcomes among newly diagnosed cancer patients in community settings. The primary goal of this meeting was to make consensus-based decisions about the design of NCORP studies around health-related social needs, screening processes, interventions, endpoints, and study design features. Read the executive summary.
For more information, contact NCI CCCT Program Director (Interim), Ramy Serour, M.S., at ramy.serour@nih.gov.